Dr. Douglas A. Winstanley, DO

Dr. Winstanley practices at West Michigan Dermatology in Holland, Michigan.

Dr. Winstanley's NPI, 1609855402, was assigned on January 11, 2006. Dr. Winstanley holds Michigan license 5101015191.

Dr. Winstanley's primary practice is West Michigan Dermatology, at 3290 N Wellness Dr, Holland, MI 49424 in Ottawa County. The practice phone is (616) 257-3344.

Dr. Winstanley's primary practice is West Michigan Dermatology in Holland, Michigan. Dr. Winstanley is also affiliated with Corewell Health Grand Rapids Hospitals - Butterworth. The medical group on file is West Michigan Dermatology. Dmand AI also links Dr. Winstanley to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winstanley practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Winstanley's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Winstanley is licensed in Michigan.

CMS data shows 1,233 Medicare services from Dr. Winstanley across 17 procedure codes in 2024, for 328 Medicare patients. Medicare paid $171,981 for them. Every service was in an office.

CMS counts 328 Medicare patients who saw Dr. Winstanley in 2024. The largest group is 75 to 84, with 140 patients. 73% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Winstanley's median patient age at 75, with 44% women.

In 2024, Dr. Winstanley wrote 243 Medicare Part D claims for 171 patients. 93% of them were for generic drugs. CMS names the drug for 178 of them, across 9 drugs with 11 or more claims each, at $182,243 in total drug cost. In 2023, CMS named 208 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Winstanley for performance year 2024, reported as part of a group. Dr. Winstanley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of melanoma (skin cancer) excision by Dr. Winstanley, more than 81% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Winstanley in 2011. The most frequent topics are Laser Therapy, Pain and Pigmentation Disorders. Dr. Winstanley has published most often in J Drugs Dermatol. Dr. Winstanley's most frequent co-authors are Joel Lee Cohen, MD and Joel Cohen, MD.

CMS Open Payments shows 196 general payments to Dr. Winstanley from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $1,469.